LOS ANGELES, May 18, 2023 – Proskauer, a leading international law firm, is pleased to announce that partner Siegmund (Sige) Gutman has been named to The Daily Journal’s Top Intellectual Property Lawyers 2023. The Daily Journal’s Top Intellectual Property Lawyers annual list recognizes leading lawyers in California who practice intellectual property and patent litigation and are honored for being on the cutting edge of new developments in patent, copyright and trademark law. This is Sige’s fourth time being named to the list. He was previously recognized in 2017, 2020 and 2021.
With more than 25 years of industry experience, Sige is an accomplished IP lawyer, handling the most complex and first-in-kind biologic drug patent and Hatch-Waxman cases in the court room. His practice focuses on developing and executing market exclusivity and freedom-to-operate strategies, including patent office and FDA regulatory strategies, for leading biologics, pharmaceutical, biotechnology and medical device clients.
As a trusted advisor to clients, the most prominent life sciences companies turn to him to litigate, and advise on, their most complex patent matters across a wide array of technologies. His recent matters include representing Amgen in a series of high-profile life sciences patent matters, including advising them on a Biologics Price Competition & Innovation Act patent infringement action brought by Janssen Biotech, Inc. relating to Amgen’s biosiomilar of Stelara® (ustekinumab).
Read Sige’s profile: Daily Journal
We are 800+ lawyers serving clients from 12 offices located in the leading financial and business centers in the Americas, Europe and Asia. We work with asset managers, private equity and venture capital firms, Fortune 500 and FTSE companies, major sports leagues, entertainment industry legends and industry-redefining companies.
Since 1875, Proskauer has been devoted to our clients’ successes. Our lawyers are known for their unusually high accessibility, responsiveness and attentiveness. We go the extra mile to understand a client’s business — and think like savvy businesspeople in the process.
Proskauer’s multidisciplinary Life Sciences Group brings together the critical skill sets and experience to litigate important intellectual property matters, create and grow life sciences companies, obtain intellectual property rights, raise capital, and negotiate and execute strategic deals.
We represent mature pharma and biotech companies in accessing and protecting markets, early-to-later-stage companies in developing new medical technologies, investors in their strategic transactions, as well as universities and other academic or research institutions in realizing commercial value from the innovation of their faculty and research staff. The myriad connections we have in this sector allow us to help clients grow their businesses by gaining access to financing, technology, partners, and markets. Working with clients at each stage of their development, our lawyers handle any challenges along the way. Whether raising capital, negotiating licensing agreements or terms of a sale, or fighting back patent challenges, our team is equipped to help life sciences companies meet their business goals.